D S Ettinger - Concepedia

Author

D S Ettinger

Johns Hopkins University

Also Known As

D Ettinger, D S Ettinger, D. Ettinger, D.S. Ettinger, David S. Ettinger, Ettinger, David S.

Publications

735

Citations

H-Index

Concepts

All Affiliations

Johns Hopkins University Johns Hopkins Medicine Johns Hopkins Hospital Vanderbilt University

About

D S Ettinger is an author at Johns Hopkins University specializing in medicine, cancer research, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	496
2	Pharmacology	5	5	330
3	Pathology	4	4	116
4	Health Sciences	2	2	155
5	Immunology	1	1	37

D S Ettinger

Publications

609

Citations

H-Index

Page 1

	Year	Citations
Phase I and pharmacological study of the novel topoisomerase I inhibitor 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin (CPT-11) administered as a ninety-minute infusion every 3 weeks. Eric K. Rowinsky, L B Grochow, D S Ettinger, PubMed Cpt AnaloguesPharmacotherapyMetronomic ChemotherapyTranslational PharmacologyPre-clinical Pharmacology	1994	195
A randomized comparison of standard chemotherapy versus alternating chemotherapy and maintenance versus no maintenance therapy for extensive-stage small-cell lung cancer: a phase III study of the Eastern Cooperative Oncology Group. D S Ettinger, Dianne M. Finkelstein, Martin D. Abeloff, Journal of Clinical Oncology Cancer ManagementPharmacotherapyMetronomic ChemotherapyCancer ChemotherapyOncology	1990	105
Alternating chemotherapy and twice-daily thoracic radiotherapy in limited-stage small-cell lung cancer: a pilot study of the Eastern Cooperative Oncology Group. Douglas H. Johnson, Andrew T. Turrisi, A. Y. Chang, Journal of Clinical Oncology	1993	67
The clinical significance of variant-morphology small-cell carcinoma of the lung. Seena C. Aisner, Dianne M. Finkelstein, D S Ettinger, Journal of Clinical Oncology Tumoral PathologyHealth SciencesMalignant DiseaseMedicineMultiple Pulmonary Nodule	1990	50
Phase I and pharmacokinetic study of brequinar sodium (NSC 368390). D A Noe, Eric K. Rowinsky, H S Shen, PubMed Molecular PharmacologyMedicinal ChemistryPharmacokinetic ModelingPharmacodynamicsDrug Kinetics	1990	42
Phase I and pharmacologic study of hexamethylene bisacetamide in patients with advanced cancer. Eric K. Rowinsky, D S Ettinger, L B Grochow, Journal of Clinical Oncology Medicinal ChemistryAdvanced CancerOncologyChemoprevention StrategyPolar-planar Compounds	1986	38
Intermittent high-dose cyclophosphamide chemotherapy for small cell carcinoma of the lung. D S Ettinger, Judith E. Karp, Martin D. Abeloff, PubMed ImmunologyPathologyPharmacotherapyMetronomic ChemotherapyCancer Chemotherapy	1978	37
A Phase II study of all-trans-retinoic acid plus cisplatin and etoposide in patients with extensive stage small cell lung carcinoma Gregory P. Kalemkerian, Michael R. Jiroutek, D S Ettinger, Cancer	1998	30
The place of ifosfamide in chemotherapy of small cell lung cancer: The Eastern Cooperative Oncology Group experience and a selected literature update D S Ettinger Lung Cancer OncologyLiterature UpdateMedicineCancer ManagementPathology	1995	18
Concurrent paclitaxel-containing regimens and thoracic radiation therapy for limited-disease small cell lung cancer. D S Ettinger PubMed	1999	16

Page 1